OTC and acute lymphoblastic leukemia: Interestingly, although endogenous or genetic upregulation of argininosuccinate synthase or ornithine transcarbamylase rescues ALL survival from a moderately low arginine condition, these enzymes cannot prevent the cytotoxic effects of peg-Arg I towards ALL (138).